国家癌症系统特征和前列腺癌结果:对全球数据的分析
Edward Christopher Dee1, Ranvir Iyengar1, Aditya Narayan2
1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
The Prostate
|April 16, 2025
概括
更强大的外科劳动力,全民医疗覆盖 (UHC),放射治疗准入,以及人均GDP的提高,都与全球更好的前列腺癌存活率有关. 这些卫生系统因素可以指导未来的癌症控制计划.
科学领域:
- 全球健康 全球健康
- 在瘤学瘤学.
- 卫生系统研究 卫生系统研究
背景情况:
- 前列腺癌是全球男性的主要癌症,预计到2040年病例将翻一番.
- 了解卫生系统因素对于有效的前列腺癌控制计划至关重要.
研究的目的:
- 确定与前列腺癌死亡率与发病率 (MIR) 相关的卫生系统指标.
- 为应对全球前列腺癌负担日益增加的健康系统规划提供信息.
主要方法:
- 使用国家卫生系统指标和来自国际癌症研究机构 (IARC) 的前列腺癌数据的生态横截面研究.
- 分析包括死亡率与发病率 (MIR) 以及GDP,UHC指数,外科工作人员和放射治疗中心等因素.
- 用单变量和多变量线性回归模型来评估关联.
主要成果:
- 分析了185个国家的数据;123个国家有完整的数据用于最终的多变量模型.
- 外科工作人员,UHC指数,每1000名人口的放射治疗中心和人均GDP独立地与较低 (改善) 的前列腺癌MIR相关.
- 最终的多变量模型解释了MIR变化的84.08% (R2=0.8408).
结论:
- 改善前列腺癌的结果与强大的外科工作人员,全民医疗覆盖 (UHC),可获得的放射治疗和人均GDP更高有关.
- 这些发现突出了加强卫生系统的关键领域,以应对日益增长的前列腺癌全球负担.
- 建议在公众卫生工作中优先考虑在公平的癌症护理系统中获得手术和放射治疗.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
12.9K
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.5K
相关概念视频
01:21Cancer Survival Analysis
303
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
303
01:20Comparing the Survival Analysis of Two or More Groups
90
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
90
01:24Kaplan-Meier Approach
57
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
57